+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Hepatitis Tests - Medical Devices Pipeline Assessment, 2020

  • ID: 5231013
  • Report
  • December 2020
  • Region: Global
  • 177 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 2
Summary

The publisher's Medical Devices sector report, “Hepatitis Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Hepatitis Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Hepatitis Test Kits are used to detect or diagnose Hepatitis virus. It includes the sub-segments Hepatitis B Tests and Hepatitis C Tests.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Hepatitis Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Hepatitis Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Hepatitis Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
Note: Product cover images may vary from those shown
2 of 2
1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Hepatitis Tests Overview

3 Products under Development
3.1 Hepatitis Tests - Pipeline Products by Stage of Development
3.2 Hepatitis Tests - Pipeline Products by Segment
3.3 Hepatitis Tests - Pipeline Products by Territory
3.4 Hepatitis Tests - Pipeline Products by Regulatory Path
3.5 Hepatitis Tests - Pipeline Products by Estimated Approval Date

4 Hepatitis Tests - Pipeline Products under Development by Companies
4.1 Hepatitis Tests Companies - Pipeline Products by Stage of Development
4.2 Hepatitis Tests - Pipeline Products by Stage of Development

5 Hepatitis Tests Companies and Product Overview
5.1 Abbott Diagnostics Company Overview
5.1.1 Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
5.2 Access Bio Inc Company Overview
5.2.1 Access Bio Inc Pipeline Products & Ongoing Clinical Trials Overview
5.3 Aldatu Biosciences Inc Company Overview
5.3.1 Aldatu Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
5.4 Alderon Biosciences Inc Company Overview
5.4.1 Alderon Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
5.5 AutoGenomics Inc Company Overview
5.5.1 AutoGenomics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.6 AXO Science SAS Company Overview
5.6.1 AXO Science SAS Pipeline Products & Ongoing Clinical Trials Overview
5.7 Beckman Coulter Inc Company Overview
5.7.1 Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview
5.8 Biokit SA Company Overview
5.8.1 Biokit SA Pipeline Products & Ongoing Clinical Trials Overview
5.9 Biomagnetics Diagnostics Corp Company Overview
5.9.1 Biomagnetics Diagnostics Corp Pipeline Products & Ongoing Clinical Trials Overview
5.10 Bio-Rad Laboratories Inc Company Overview
5.10.1 Bio-Rad Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
5.11 Boditech Med Inc Company Overview
5.11.1 Boditech Med Inc Pipeline Products & Ongoing Clinical Trials Overview
5.12 Celera Corp Company Overview
5.12.1 Celera Corp Pipeline Products & Ongoing Clinical Trials Overview
5.13 CeMines, Inc. (Inactive) Company Overview
5.13.1 CeMines, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.14 Cepheid Inc Company Overview
5.14.1 Cepheid Inc Pipeline Products & Ongoing Clinical Trials Overview
5.15 China Medical Technologies Inc (Inactive) Company Overview
5.15.1 China Medical Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.16 Co-Diagnostics Inc Company Overview
5.16.1 Co-Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.17 Corgenix Medical Corp Company Overview
5.17.1 Corgenix Medical Corp Pipeline Products & Ongoing Clinical Trials Overview
5.18 CrossLife Technologies Inc Company Overview
5.18.1 CrossLife Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.19 Daan Gene Co Ltd Company Overview
5.19.1 Daan Gene Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.20 Diagnostics for the Real World (Europe) Ltd Company Overview
5.20.1 Diagnostics for the Real World (Europe) Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.21 DiaSorin SpA Company Overview
5.21.1 DiaSorin SpA Pipeline Products & Ongoing Clinical Trials Overview
5.22 D-Kimia, LLC. Company Overview
5.22.1 D-Kimia, LLC. Pipeline Products & Ongoing Clinical Trials Overview
5.23 DNAE Group Holdings Ltd Company Overview
5.23.1 DNAE Group Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.24 DxDiscovery Inc Company Overview
5.24.1 DxDiscovery Inc Pipeline Products & Ongoing Clinical Trials Overview
5.25 Ecoli sro Company Overview
5.25.1 Ecoli sro Pipeline Products & Ongoing Clinical Trials Overview
5.26 Ferrer inCode SL Company Overview
5.26.1 Ferrer inCode SL Pipeline Products & Ongoing Clinical Trials Overview
5.27 Fujirebio Diagnostics Inc Company Overview
5.27.1 Fujirebio Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.28 Genome Diagnostics Pvt Ltd Company Overview
5.28.1 Genome Diagnostics Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.29 HealthTell Inc Company Overview
5.29.1 HealthTell Inc Pipeline Products & Ongoing Clinical Trials Overview
5.30 Hepron Molecular Lab Inc Company Overview
5.30.1 Hepron Molecular Lab Inc Pipeline Products & Ongoing Clinical Trials Overview
5.31 Hologic Inc Company Overview
5.31.1 Hologic Inc Pipeline Products & Ongoing Clinical Trials Overview
5.32 Imperial College London Company Overview
5.32.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
5.33 LifeAssay Diagnostics (Pty) Ltd Company Overview
5.33.1 LifeAssay Diagnostics (Pty) Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.34 MedMira Inc Company Overview
5.34.1 MedMira Inc Pipeline Products & Ongoing Clinical Trials Overview
5.35 Medosome Biotec LLC Company Overview
5.35.1 Medosome Biotec LLC Pipeline Products & Ongoing Clinical Trials Overview
5.36 Monogram Biosciences Inc Company Overview
5.36.1 Monogram Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
5.37 NanoDiagX Company Overview
5.37.1 NanoDiagX Pipeline Products & Ongoing Clinical Trials Overview
5.38 Ortho-Clinical Diagnostics Inc Company Overview
5.38.1 Ortho-Clinical Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.39 Paramedical Srl Company Overview
5.39.1 Paramedical Srl Pipeline Products & Ongoing Clinical Trials Overview
5.40 ProteinLogic Ltd Company Overview
5.40.1 ProteinLogic Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.41 Qiagen NV Company Overview
5.41.1 Qiagen NV Pipeline Products & Ongoing Clinical Trials Overview
5.42 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Company Overview
5.42.1 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Pipeline Products & Ongoing Clinical Trials Overview
5.43 Roche Diagnostics International Ltd Company Overview
5.43.1 Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.44 Seegene Inc Company Overview
5.44.1 Seegene Inc Pipeline Products & Ongoing Clinical Trials Overview
5.45 Shenzhen Mindray Bio-Medical Electronics Co Ltd Company Overview
5.45.1 Shenzhen Mindray Bio-Medical Electronics Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.46 Siemens Healthcare Diagnostics Inc Company Overview
5.46.1 Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.47 Siemens Healthineers AG Company Overview
5.47.1 Siemens Healthineers AG Pipeline Products & Ongoing Clinical Trials Overview
5.48 Stanford University Company Overview
5.48.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview
5.49 Syamala Srinivasa Life Sciences Pvt. Ltd Company Overview
5.49.1 Syamala Srinivasa Life Sciences Pvt. Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.50 Sysmex Corp Company Overview
5.50.1 Sysmex Corp Pipeline Products & Ongoing Clinical Trials Overview
5.51 TBG Diagnostics Ltd Company Overview
5.51.1 TBG Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.52 The University of British Columbia Company Overview
5.52.1 The University of British Columbia Pipeline Products & Ongoing Clinical Trials Overview
5.53 University Medical Center Hamburg-Eppendorf Company Overview
5.53.1 University Medical Center Hamburg-Eppendorf Pipeline Products & Ongoing Clinical Trials Overview
5.54 University of Michigan Company Overview
5.54.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview
5.55 University of Texas Medical Branch at Galveston Company Overview
5.55.1 University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview
5.56 University of Warwick Company Overview
5.56.1 University of Warwick Pipeline Products & Ongoing Clinical Trials Overview
5.57 Ustar Biotechnologies (Hangzhou) Ltd. Company Overview
5.57.1 Ustar Biotechnologies (Hangzhou) Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.58 Xiamen Zeesan Biotech Co.,Ltd Company Overview
5.58.1 Xiamen Zeesan Biotech Co.,Ltd Pipeline Products & Ongoing Clinical Trials Overview

6 Hepatitis Tests- Recent Developments
6.1 Nov 18, 2020: Change in use of proceeds from the global offering for expansion of R&D portfolio into hepatitis B clinical cure and NASH
6.2 Oct 23, 2020: Mentice receives order of total SEK 7.1 million from ABBOTT
6.3 Aug 20, 2020: Vir Biotechnology presents data on VIR-2218 from clinical studies for the treatment of hepatitis B at the EASL Digital International Liver Congress
6.4 Jul 08, 2020: GenMark Diagnostics: Entry into a Material Definitive Agreement
6.5 Jun 09, 2020: Siemens and Exyte join forces to deliver integrated solutions for fast-track construction of smart biotech facilities
6.6 May 28, 2020: QIAGEN builds on leading position in Precision Medicine with novel solutions in oncology
6.7 May 18, 2020: QIAGEN announces publication of Reasoned Position Statement for proposed acquisition by Thermo Fisher and date for Annual General Meeting
6.8 May 13, 2020: OPKO Health's BioReference Laboratories and Westchester Medical Center Health Network enter into strategic laboratory collaboration to deliver operational and diagnostic services
6.9 Apr 16, 2020: Abbott reports first-quarter 2020 results
6.10 Feb 26, 2020: bioMerieux – 2019 financial results
6.11 Feb 18, 2020: Hologic Expands Costa Rican operations with new financial shared services center
6.12 Feb 13, 2020: LabCorp announces 2019 fourth quarter and full year results and provides 2020 guidance
6.13 Feb 13, 2020: Bio-Rad reports fourth-quarter and full-year 2019 financial results
6.14 Feb 11, 2020: Abbott Laboratories: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officer
6.15 Feb 05, 2020: Hologic launches new scalable options for panther system in the United States and Europe
6.16 Feb 04, 2020: Bio-Rad brings FCS express flow cytometry analysis software to ZE5 cell analyzer users
6.17 Feb 03, 2020: Siemens Healthineers starts new fiscal year with strong growth – outlook confirmed
6.18 Jan 30, 2020: Quotient provides an update on recent MosaiQ milestone achievements together with third quarter fiscal 2020 results
6.19 Jan 22, 2020: Abbott reports fourth-quarter 2019 results; announces strong forecast for 2020
6.20 Jan 13, 2020: GenMark Diagnostics provides preliminary operational and financial results for 2019
6.21 Jan 13, 2020: Enzo Biochem responds to series of misleading and inaccurate statements from activist hedge fund harbert
6.22 Jan 12, 2020: Hologic announces preliminary financial results for first quarter of fiscal 2020
6.23 Jan 08, 2020: ABBOTT LABORATORIES: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers.
6.24 Jan 07, 2020: Quotient announces appointment of new chief financial officer Peter Buhler and chief operating officer Ed Farrell
6.25 Jan 06, 2020: Bio-Rad appoints Dara Grantham Wright Executive Vice President and Clinical Diagnostics Group President
6.26 Dec 31, 2019: Enzo Biochem appoints Rebecca J. Fischer to Board of Directors
6.27 Dec 24, 2019: Ad-hoc announcement pursuant to article 17 market abuse regulation
6.28 Dec 23, 2019: The International Trade Commission issues final decision affirming 10X Genomics infringement of three of Bio-Rad’s Patents
6.29 Dec 13, 2019: Bio-Rad makes progress recovering from recent ransomware attack
6.30 Dec 10, 2019: Enzo Biochem reports fiscal first quarter results
6.31 Dec 10, 2019: Siemens Healthineers gives details on second phase of Strategy 2025 and on the further development of its businesses

7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Hepatitis Tests - Pipeline Products by Stage of Development
Table 2: Hepatitis Tests - Pipeline Products by Segment
Table 3: Hepatitis Tests - Pipeline Products by Territory
Table 4: Hepatitis Tests - Pipeline Products by Regulatory Path
Table 5: Hepatitis Tests - Pipeline Products by Estimated Approval Date
Table 6: Hepatitis Tests Companies - Pipeline Products by Stage of Development
Table 7: Hepatitis Tests - Pipeline Products by Stage of Development
Table 8: Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Alinity i Assay - HCV Ag - Product Status
Table 10: Alinity i Assay - HCV Ag - Product Description
Table 11: ARCHITECT c16000 System - HbSAg Assay - Product Status
Table 12: ARCHITECT c16000 System - HbSAg Assay - Product Description
Table 13: ARCHITECT c4000 System - HbSAg Assay - Product Status
Table 14: ARCHITECT c4000 System - HbSAg Assay - Product Description
Table 15: ARCHITECT c8000 System - HbSAg Next Qual Assay - Product Status
Table 16: ARCHITECT c8000 System - HbSAg Next Qual Assay - Product Description
Table 17: Access Bio Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 18: RDT - HCV Infection - Product Status
Table 19: RDT - HCV Infection - Product Description
Table 20: Aldatu Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 21: PANDAA Assay - HCV - Product Status
Table 22: PANDAA Assay - HCV - Product Description
Table 23: Alderon Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 24: eSystem - Qualitative HCV RNA Assay - Product Status
Table 25: eSystem - Qualitative HCV RNA Assay - Product Description
Table 26: AutoGenomics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 27: INFINITI High Throughput System - Hepatitis C Virus (HCV) Genotyping Test - Product Status
Table 28: INFINITI High Throughput System - Hepatitis C Virus (HCV) Genotyping Test - Product Description
Table 29: INFINITI Plus - Hepatitis C Virus (HCV) Genotyping Test - Product Status
Table 30: INFINITI Plus - Hepatitis C Virus (HCV) Genotyping Test - Product Description
Table 31: AXO Science SAS Pipeline Products & Ongoing Clinical Trials Overview
Table 32: Multiplexed Detection - Anti-HCV Antibodies - Product Status
Table 33: Multiplexed Detection - Anti-HCV Antibodies - Product Description
Table 34: Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 35: UniCel DxN - HCV Viral Load Test - Product Status
Table 36: UniCel DxN - HCV Viral Load Test - Product Description
Table 37: Biokit SA Pipeline Products & Ongoing Clinical Trials Overview
Table 38: BIO-FLASH anti-HBe Assay - Product Status
Table 39: BIO-FLASH anti-HBe Assay - Product Description
Table 40: BIO-FLASH HAV Assay - Product Status
Table 41: BIO-FLASH HAV Assay - Product Description
Table 42: BIO-FLASH HBe Ag Assay - Product Status
Table 43: BIO-FLASH HBe Ag Assay - Product Description
Table 44: Biomagnetics Diagnostics Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 45: Diagnostic Test - Hepatitis B - Product Status
Table 46: Diagnostic Test - Hepatitis B - Product Description
Table 47: Bio-Rad Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 48: BioPlex 2200 - Hepatitis Test - Product Status
Table 49: BioPlex 2200 - Hepatitis Test - Product Description
Table 50: Boditech Med Inc Pipeline Products & Ongoing Clinical Trials Overview

List of Figures
Figure 1: Hepatitis Tests - Pipeline Products by Stage of Development
Figure 2: Hepatitis Tests - Pipeline Products by Segment
Figure 3: Hepatitis Tests - Pipeline Products by Territory
Figure 4: Hepatitis Tests - Pipeline Products by Regulatory Path
Figure 5: Hepatitis Tests - Pipeline Products by Estimated Approval Date
Note: Product cover images may vary from those shown
Adroll
adroll